Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Analgesic Efficacy of TAP Block in Cesarean Section
NCT04809532Unknown
- Sponsor
- Combined Military Hospital
- Start
- Feb 2021
- Primary completion
- Apr 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of bupivacaine hydrochloride 0.75% injection in postoperative pain (2 arms), sponsored by Combined Military Hospital. Primary endpoint: Mean Postoperative Consumption of Opioids at 24 hours. Status: unknown.
02
Drugs
bupivacaine hydrochloride 0.75% injection
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT04809532.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04809532.